Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications

Cytokine

Volumn 42, Issue 2, 2008, Pages 217-221

  Altinova, Alev E ^a   Yetkin, Ilhan ^a   Akbay, Esen ^b   Bukan, Neslihan ^a   Arslan, Metin ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

Glycemic control; IL 18; Lipid; Microvascular complication; Postprandial glucose; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTERLEUKIN-18; MALE; MICROCIRCULATION;

EID: 43049173750     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.02.006     Document Type: Article

References (30)

1. Donath M.Y., Storling J., Maedler K., and Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81 (2003) 455-470
2. Targher G., Bertolini L., Zoppini G., Zenari L., and Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 22 (2005) 999-1004
3. McInnes I.B., Gracie J.A., Leung B.P., Wei X.Q., and Liew F.Y. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 21 (2000) 312-315
4. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 11 (2004) 405-410
5. Aso Y., Okumura K., Takebayashi K., Wakabayashi S., and Inukai T. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26 (2003) 2622-2627
6. Nakamura A., Shikata K., Hiramatsu M., Nakatou T., Kitamura T., Wada J., et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28 (2005) 2890-2895
7. Rothe H., Hausmann A., Casteels K., Okamura H., Kurimoto M., Burkart V., et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J Immunol 163 (1999) 1230-1236
8. Oikawa Y., Shimada A., Kasuga A., Morimoto J., Osaki T., Tahara H., et al. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol 171 (2003) 5865-5875
9. Nicoletti F., Di Marco R., Papaccio G., Conget I., Gomis R., Bernardini R., et al. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol 33 (2003) 2278-2286
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006;29(Suppl. 1):43-48.
11. Mahmoud R.A., el-Ezz S.A., and Hegazy A.S. Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Ital J Biochem 53 (2004) 73-81
12. Katakami N., Kaneto H., Matsuhisa M., Yoshiuchi K., Kato K., Yamamoto K., et al. Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients. Diabetes Care 30 (2007) 159-161
13. Nicoletti F., Conget I., Di Marco R., Speciale A.M., Morinigo R., Bendtzen K., et al. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44 (2001) 309-311
14. Qiao Q., Tuomilehto J., and Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 46 Suppl. 1 (2003) M17-M21
15. 1c in Japanese type 2 diabetic patients. Diabetes Care 28 (2005) 2806-2807
16. Cavalot F., Petrelli A., Traversa M., Bonomo K., Fiora E., Conti M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91 (2006) 813-819
17. Bosch M., Lopez-Bermejo A., Vendrell J., Musri M., Ricart W., and Fernandez-Real M. Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. Diabetologia 48 (2005) 1841-1843
18. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
19. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12 (2001) 53-72
20. Gillespie M.T., and Horwood N.J. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev 9 (1998) 109-116
21. Calder P.C., Dimitriadis G., and Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr Opin Clin Nutr Metab Care 10 (2007) 531-540
22. Wen Y., Gu J., Li S.L., Reddy M.A., Natarajan R., and Nadler J.L. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology 147 (2006) 2518-2525
23. Moriwaki Y., Yamamoto T., Shibutani Y., Aoki E., Tsutsumi Z., Takahashi S., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52 (2003) 605-608
24. Blankenberg S., Tiret L., Bickel C., Peetz D., Cambien F., Meyer J., et al. AtheroGene investigators: interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
25. Zaremba J., and Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 24 (2003) 117-124
26. Dai S.M., Matsuno H., Nakamura H., Nishioka K., and Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1 beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 50 (2004) 432-443
27. Marino E., and Cardier J.E. Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95). Cytokine 22 (2003) 142-148
28. Stuyt R.J., Netea M.G., Geijtenbeek T.B., Kullberg B.J., Dinarello C.A., and van der Meer J.W. Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology 110 (2003) 329-334
29. Grunfeld C., and Feingold K.R. Regulation of lipid metabolism by cytokines during host defense. Nutrition 12 Suppl. l (1996) S24-S26
30. Jin W., Millar J.S., Broedl U., Glick J.M., and Rader D.J. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest 111 (2003) 357-362